[Hydroxycamptothecine and ifosfamide as second-line therapy in non-small cell lung cancer after prior treatment with platinum-based regimens].

Xu, Ying

[Hydroxycamptothecine and ifosfamide as second-line therapy in non-small cell lung cancer after prior treatment with platinum-based regimens]. [electronic resource] - Zhongguo fei ai za zhi = Chinese journal of lung cancer Feb 2005 - 45-7 p. digital

Publication Type: English Abstract; Journal Article

1009-3419

10.3779/j.issn.1009-3419.2005.01.10 doi